Multiparametric magnetic resonance imaging (mpMRI) has become an indispensable radiographic tool in diagnosing prostate cancer. However, mpMRI fails to visualize ~15% of clinically significant PCa (csPCa).
Multiparametric magnetic resonance imaging (mpMRI) has become an indispensable radiographic tool in diagnosing prostate cancer. However, mpMRI fails to visualize ~15% of clinically significant PCa (csPCa).